Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stroke
Pharma
NIH stops Xarelto arm of stroke trial due to safety, efficacy
An independent data monitoring board identified “an increase in safety events and evidence of futility” for the Xarelto arm, the NIH said.
Angus Liu
Feb 10, 2026 4:04pm
Pfizer confirms patient death in hemophilia drug trial
Dec 23, 2025 11:05am
Amgen's Repatha meets the mark in CV primary prevention trial
Oct 2, 2025 11:26am
FDA approves Roche's heart attack med TNKase to treat stroke
Mar 3, 2025 3:19pm
FDA approves Agepha’s version of colchicine for heart disease
Jun 20, 2023 8:10am
Nasal delivery gets antibody to rodent brains to treat stroke
Jan 24, 2023 6:40am
